ライフサイエンスコーパス: atomic bomb

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 rent from the whole body radiation after the atomic bombs.

2 Prominent (14)C features, such as the atomic bomb (14)C peak, can be resolved by scanning seve

3 and genetic studies of the survivors of the atomic bombs and of their children.

4 ncer risks in a U.S. population derived from atomic bomb-associated cancer mortality data, together w

5 For 50 years, the Atomic Bomb Casualty Commission (ABCC) and its successor

6 f employment culminated in his work with the Atomic Bomb Casualty Commission on human chromosomes, fo

7 e cancer incidence found in survivors of the atomic bombs dropped in Hiroshima and Nagasaki, the Inte

8 idemiologic cohort study of survivors of the atomic bombs dropped on Hiroshima and Nagasaki, Japan.

9 e relative risks among Japanese survivors of atomic-bomb explosions are greater than those among comp

10 in cultured lymphocytes, of exposure to the atomic bomb in Hiroshima have been reanalyzed to determi

11 Data from the survivors of the atomic bombs serve as the major basis for risk calculati

12 t radiobiologic estimates, based on Japanese atomic bomb survivor data, indicate a substantially high

13 ectation based on cytogenetic experience and atomic bomb survivor data.

14 The model is fitted to the Japanese atomic bomb survivor leukaemia incidence data, and data

15 diation doses are reasonably understood from atomic bomb survivor studies, there is much more uncerta

16 gh-dose cancer risks, based only on data for atomic bomb survivors (who were exposed to lower total d

17 incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative a

18 were derived from cancer incidence data for atomic bomb survivors and used to calculate the excess l

19 Hereditary effects in the children of atomic bomb survivors have not been detected.

20 The Life Span Study of atomic bomb survivors is an important source of risk est

21 in the Life Span Study, a study of Japanese atomic bomb survivors who were aged 15-64 years at the t

22 These include studies of atomic bomb survivors, nuclear industry workers, and chi

23 ow-up data through 2002 from 77,752 Japanese atomic bomb survivors, we identified 14,048 participants

24 nd risk models, based mainly on the Japanese atomic bomb survivors, with population-based cancer inci

25 direct evidence of increased cancer risk in atomic bomb survivors.

26 ct evidence of increased cancer mortality in atomic bomb survivors.

27 s and a cohort of radiation-exposed Japanese atomic bomb survivors.

28 risk estimates have been derived mainly from atomic bomb survivors.

29 y consistent with estimates for the Japanese atomic bomb survivors.

30 incidence and mortality data in the Japanese atomic-bomb survivors were analyzed using relative and a

31 s in the medical series than in the Japanese atomic-bomb survivors, and dose-fractionation effects.

32 On the morning of July 16, 1945, the first atomic bomb was exploded in New Mexico on the White Sand

33 rgely dependent on evidence from exposure to atomic bomb whole body radiation, leading to increases i

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。